Since the discovery of induced pluripotent stem cells (iPSCs) in 2006, the field has witnessed tremendous progress over the past two decades. This progress has enabled the widespread use of these cells and their derivatives, including differentiated cells and organoids, in modeling neurological diseases, understanding pathological mechanisms, and developing cell therapies.



